[WEBINAR] Building flow chemistry workstations for fast reaction screening and optimization
[WEBINAR] In this webinar, we share methods to screen and optimize reactions under extreme time constraints using flow chemistry setups integrated with PAT.
Cutting edge process development insights and news from APC.
[WEBINAR] In this webinar, we share methods to screen and optimize reactions under extreme time constraints using flow chemistry setups integrated with PAT.
Predicting the percolation threshold, using statistical models or experimentation, is an evidence-based approach that can get solid dosage forms designed faster.
[WEBINAR] Traditional solvent screening takes too long to fix issues for fast-moving clinical candidates. But modeling & smart experiments speed things up.
Computational fluid dynamics virtual experiments let pharma and biotech teams solve process challenges before entering the lab, cutting development time and resource use.
Taoiseach Micheál Martin visited APC's Dublin facility to review Ireland's COVID-19 vaccine development programme in partnership with Australian biotech firm Vaxine.
APC’s CEO Dr Mark Barrett, discusses Ireland’s involvement in the pharmaceutical industry and APC’s current plans on developing a COVID-19 vaccine in partnership with Vaxine Pty Ltd.
APC and Vaxine partner to accelerate development of COVAX-19, combining BioACHIEVE process development with Advax adjuvant technology to reduce vaccine timelines.
APC has joined the Advanced Mammalian Biomanufacturing Innovation Center (AMBIC) as one of the 26 industrial partners.
A Message from the APC Team to Collaborators, "Now, more than ever, collaboration is vital."
Takeda Biologics and APC announced a collaboration using CFD modelling, PAT, and informatics to identify scale-independent process improvements for rare disease biologics manufacturing.